BioLargo (BLGO) Competitors

Luxfer (NYSE:LXFR) and BioLargo (NASDAQ:BLGO) are both small-cap industrials companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, community ranking, risk, media sentiment, valuation, dividends and profitability.

Which has more volatility and risk, LXFR or BLGO?

Luxfer has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, BioLargo has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500.

Does the MarketBeat Community favor LXFR or BLGO?

Luxfer received 180 more outperform votes than BioLargo when rated by MarketBeat users. Likewise, 66.59% of users gave Luxfer an outperform vote while only 60.99% of users gave BioLargo an outperform vote.

Company	Underperform	Outperform
Luxfer	Outperform Votes 291 66.59%	Underperform Votes 146 33.41%
BioLargo	Outperform Votes 111 60.99%	Underperform Votes 71 39.01%

Does the media favor LXFR or BLGO?

In the previous week, Luxfer had 4 more articles in the media than BioLargo. MarketBeat recorded 4 mentions for Luxfer and 0 mentions for BioLargo. Luxfer's average media sentiment score of 0.63 beat BioLargo's score of 0.00 indicating that Luxfer is being referred to more favorably in the media.

Company	Overall Sentiment
Luxfer	Positive
BioLargo	Neutral

Do insiders & institutionals hold more shares of LXFR or BLGO?

90.8% of Luxfer shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 1.2% of Luxfer shares are held by insiders. Comparatively, 20.3% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is LXFR or BLGO more profitable?

Luxfer has a net margin of 2.37% compared to BioLargo's net margin of -11.45%. Luxfer's return on equity of 9.26% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Luxfer	2.37%	9.26%	5.13%
BioLargo	-11.45%	-39.90%	-22.06%

Which has better valuation & earnings, LXFR or BLGO?

Luxfer has higher revenue and earnings than BioLargo. BioLargo is trading at a lower price-to-earnings ratio than Luxfer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Luxfer	$391.90M	0.67	-$1.90M	$0.68	14.50
BioLargo	$12.23M	5.72	-$3.50M	-$0.01	-23.20

Summary

Luxfer beats BioLargo on 13 of the 15 factors compared between the two stocks.